Envoy Medical, Inc. (NASDAQ:COCH) Sees Significant Decrease in Short Interest

Envoy Medical, Inc. (NASDAQ:COCH) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totalling 158,800 shares, a decline of 34.7% from the December 15th total of 243,100 shares. Approximately 1.8% of the company’s shares are short sold. Based on an average daily volume of 239,400 shares, the short-interest ratio is presently 0.7 days.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. Ascendiant Capital Markets increased their price target on shares of Envoy Medical from $8.75 to $9.00 and gave the stock a “buy” rating in a research note on Friday, December 6th. Brookline Capital Management started coverage on Envoy Medical in a research report on Monday, October 14th. They set a “buy” rating and a $9.00 price target on the stock.

Envoy Medical Stock Performance

Shares of COCH opened at $1.40 on Wednesday. The firm’s 50-day simple moving average is $1.89 and its two-hundred day simple moving average is $2.42. Envoy Medical has a fifty-two week low of $1.08 and a fifty-two week high of $11.46.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.